Loading...
XTAE
TGTR
Market cap15mUSD
Apr 29, Last price  
409.60ILS
1D
-1.54%
1Q
-0.19%
Jan 2017
-44.10%
Name

Together Pharma Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
62.18
EPS
—
Div Yield, %
—
Shrs. gr., 5y
16.07%
Rev. gr., 5y
%
Revenues
91m
+191.42%
37,3371,189,3867,586,09612,114,113000011,223,00012,026,00031,228,00091,006,000
Net income
-4m
L-87.13%
-12,970,873-4,483,606-5,470,405-3,838,052-1,733,760-34,000-149,863,000-15,276,0007,152,000-13,776,000-33,524,000-4,316,000
CFO
15m
P
-4,872,478-3,859,438-2,657,276-4,169,254-3,417,4330-5,379,000-6,833,000-9,703,000-18,644,000-13,733,00014,831,000
Dividend
Mar 29, 20111.5089 ILS/sh

Profile

Together Pharma Ltd, through its subsidiaries, engages in growing, production, storage, and distribution of medical cannabis products in Israel. The company was incorporated in 1991 and is based in Ashkelon, Israel.
URL
https://www.together-pharma.com/
IPO date
May 01, 1993
Employees
70
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
91,006
191.42%
31,228
159.67%
Cost of revenue
68,912
48,727
Unusual Expense (Income)
NOPBT
22,094
(17,499)
NOPBT Margin
24.28%
Operating Taxes
4,073
847
Tax Rate
18.43%
NOPAT
18,021
(18,346)
Net income
(4,316)
-87.13%
(33,524)
143.35%
Dividends
Dividend yield
Proceeds from repurchase of equity
11,528
BB yield
-57.04%
Debt
Debt current
18,407
21,678
Long-term debt
48,650
49,423
Deferred revenue
875
Other long-term liabilities
54,868
30,554
Net debt
63,465
65,707
Cash flow
Cash from operating activities
14,831
(13,733)
CAPEX
(866)
(333)
Cash from investing activities
(1,616)
33,045
Cash from financing activities
(14,920)
(19,143)
FCF
9,820
13,348
Balance
Cash
3,592
5,296
Long term investments
98
Excess cash
3,833
Stockholders' equity
(2,551)
190,578
Invested Capital
109,671
89,293
ROIC
18.11%
ROCE
20.63%
EV
Common stock shares outstanding
8,785
8,149
Price
3.88
56.45%
2.48
-76.65%
Market cap
34,088
68.67%
20,210
-72.22%
EV
102,795
276,921
EBITDA
45,948
(11,496)
EV/EBITDA
2.24
Interest
17,036
Interest/NOPBT